NCT07441837: Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients
- State
- Not started
- Phase
- Phase 2
- People
- 60 planned
- Started
- 1 Jul 2026
- Primary completion
- 1 Aug 2028
- Arms
- Tb-161 PSMA treatment arm
- Results
- None posted
- 2 Mar 2026: Trial registered
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.